Old Web
English
Sign In
Acemap
>
Paper
>
1387P Phase Ib study of LXH254 + LTT462 in patients with KRAS- or BRAF-mutant NSCLC
1387P Phase Ib study of LXH254 + LTT462 in patients with KRAS- or BRAF-mutant NSCLC
2020
Juergen Wolf
D. Planchard
Rebecca S. Heist
Ben Solomon
M Sebastián
Armando Santoro
N. Reguart
Uz Stammberger
L. Manganelli
H. Wu
A Mais
C. Dooms
Keywords:
Cancer research
in patient
KRAS
Mutant
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]